Modified Opsonization, Phagocytosis, and Killing Assays to Measure Potentially Protective Antibodies Against Pneumococcal Surface Protein A

Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00371-13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pneumococcal Surface Protein a Is Expressed in Vivo, and Antibodies to PspA Are Effective for Therapy in a Murine Model of Pneumococcal Sepsis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2003English

Domains of Group a Streptococcal M Protein That Confer Resistance to Phagocytosis, Opsonization and Protection: Implications for Vaccine Development

Molecular Microbiology
MicrobiologyMolecular Biology
2006English

Intradermal Immunization of Mice With Cholera Toxin B-Pneumococcal Surface Protein a Fusion Protein Is Protective Against Intraperitoneal Challenge With Streptococcus Pneumoniae

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2005English

Viability and Virulence of Pneumolysin, Pneumococcal Surface Protein A, and Pneumolysin/Pneumococcal Surface Protein a Mutants in the Ear

JAMA Otolaryngology - Head and Neck Surgery
MedicineOtorhinolaryngologySurgery
2013English

Characterization of Protective Immune Responses Induced by Pneumococcal Surface Protein a in Fusion With Pneumolysin Derivatives

PLoS ONE
Multidisciplinary
2013English

Taking Sharper Pictures of Malaria With Combined Antibodies to Measure Exposure Recency Assays

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2018English

Antibodies Against a Surface Protein of Streptococcus Pyogenes Promote a Pathological Inflammatory Response

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2008English

Functional Antibodies as Immunological Endpoints to Evaluate Protective Immunity Against Shigella

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Development and Optimization of a Novel Assay to Measure Neutralizing Antibodies Against Clostridium Difficile Toxins

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy